Largest companies by cash on hand
cash on hand
| Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 1 | $20.42B | Healthcare | Pharmaceuticals | United States | NYSE |
| 2 | $8.95B | Healthcare | Pharmaceuticals | United States | NYSE |
| 3 | $6.85B | Healthcare | Pharmaceuticals | United States | NYSE |
| 4 | $6.57B | Healthcare | Pharmaceuticals | United States | NYSE |
| 5 | $6.14B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 6 | $5.10B | Healthcare | Pharmaceuticals | United States | NYSE |
| 7 | $5.10B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 8 | $2.46B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 9 | $1.80B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 10 | $1.71B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 11 | $1.62B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 12 | $1.48B | Healthcare | Pharmaceuticals | United States | NYSE |
| 13 | $1.25B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 14 | $1.13B | Healthcare | Pharmaceuticals | United States | NYSE |
| 15 | $1.09B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 16 | $1.05B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 17 | $1.01B | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 18 | $976.00M | Healthcare | Pharmaceuticals | United States | NYSE |
| 19 | $886.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 20 | $874.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 21 | $811.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 22 | $677.91M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 23 | $676.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 24 | $598.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 25 | $570.39M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 26 | $549.77M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 27 | $544.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 28 | $530.00M | Healthcare | Pharmaceuticals | United States | NYSE |
| 29 | $511.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 30 | $482.57M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 31 | $474.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 32 | $424.15M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 33 | $420.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 34 | $419.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 35 | $413.03M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 36 | $399.70M | Healthcare | Pharmaceuticals | United States | NYSE |
| 37 | $384.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 38 | $368.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 39 | $360.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 40 | $350.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 41 | $345.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 42 | $336.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 43 | $330.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 44 | $319.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 45 | $319.33M | Healthcare | Pharmaceuticals | United States | NYSE |
| 46 | $300.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 47 | $292.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 48 | $288.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 49 | $284.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 50 | $283.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 51 | $272.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 52 | $268.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 53 | $264.20M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 54 | $258.60M | Healthcare | Pharmaceuticals | United States | NYSE |
| 55 | $257.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 56 | $256.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 57 | $255.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 58 | $243.73M | Healthcare | Pharmaceuticals | United States | NYSE |
| 59 | $222.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 60 | $219.11M | Healthcare | Pharmaceuticals | United States | NYSE |
| 61 | $217.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 62 | $205.88M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 63 | $199.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 64 | $196.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 65 | $196.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 66 | $187.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 67 | $182.48M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 68 | $181.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 69 | $179.97M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 70 | $179.95M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 71 | $179.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 72 | $175.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 73 | $172.80M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 74 | $171.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 75 | $169.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 76 | $168.02M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 77 | $166.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 78 | $164.99M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 79 | $162.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 80 | $155.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 81 | $155.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 82 | $154.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 83 | $147.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 84 | $145.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 85 | $139.70M | Healthcare | Pharmaceuticals | United States | NYSE |
| 86 | $138.34M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 87 | $138.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 88 | $136.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 89 | $135.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 90 | $130.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 91 | $129.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 92 | $127.64M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 93 | $125.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 94 | $122.83M | Healthcare | Pharmaceuticals | — | Nasdaq |
| 95 | $121.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 96 | $120.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 97 | $119.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 98 | $117.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 99 | $117.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 100 | $117.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 317 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.